Ashish K. Kulkami, PhD of Avantor, Anne S. Lindblad, PhD of The Emmes Corporation, and Kurt Newman, MD of Children’s National Health System, Join BHI’s Board
BioHealth Innovation, Inc. (BHI) announced that its Board of Directors has unanimously approved the appointments of three new board members, Ashish K. Kulkarni, PhD, Executive Vice President and Chief Technology Officer of Avantor, Anne S. Lindblad, PhD, President and CEO, The Emmes Corporation, and Kurt Newman, MD, President and Chief Executive Officer, Children’s National Health System.
“I am honored to welcome our new members to the board,” said Richard Bendis, BHI President and CEO. “Ashish, Anne, and Kurt bring years of biohealth experience and fresh perspectives to our board.”
Ashish K. Kulkarni, Ph.D., has been Executive Vice President and Chief Technology Officer of Avantor since 2016. Dr. Kulkarni has extensive experience serving as Chief Technology Officer for other large global companies. Prior to joining Avantor, Dr. Kulkarni acted as Chief Technology and Innovation Officer at Celanese Corporation, from 2012 to 2016, and Vice President of Research and Development for the Advanced Engineering Materials and Emulsions business units, from 2010 to 2012. Dr. Kulkarni also previously acted as Vice President of Global Engineering, Building Systems and Services division of United Technologies Corporation, from 2007 to 2010. In addition, Dr. Kulkarni served in various leadership roles with American Standard. He started his career with General Electric Company on their Technical Leadership Program (TLP).